Cargando…

Assessment of Treatment Strategies to Achieve Hepatitis C Elimination in Canada Using a Validated Model

IMPORTANCE: Achievement of the World Health Organization (WHO) target of eliminating hepatitis C virus (HCV) by 2030 will require an increase in key services, including harm reduction, HCV screening, and HCV treatment initiatives in member countries. These data are not available for Canada but are i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Binka, Mawuena, Janjua, Naveed Z., Grebely, Jason, Estes, Chris, Schanzer, Dena, Kwon, Jisoo A., Shoukry, Naglaa H., Kwong, Jeffrey C., Razavi, Homie, Feld, Jordan J., Krajden, Mel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2020
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203608/ https://www.ncbi.nlm.nih.gov/pubmed/32374397 http://dx.doi.org/10.1001/jamanetworkopen.2020.4192

Ejemplares similares

The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada
por: Janjua, Naveed, et al.
Publicado: (2022)

Association of COVID-19 Infection With Incident Diabetes
por: Naveed, Zaeema, et al.
Publicado: (2023)

Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada
por: Samji, Hasina, et al.
Publicado: (2020)

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada
por: Binka, Mawuena, et al.
Publicado: (2018)

Real-world Effectiveness of Sofosbuvir/Velpatasvir for Treatment of Chronic Hepatitis C in British Columbia, Canada: A Population-Based Cohort Study
por: Wilton, James, et al.
Publicado: (2020)

Risk factors for COVID-19 hospitalization after COVID-19 vaccination: a population-based cohort study in Canada
por: Velásquez García, Héctor A., et al.
Publicado: (2023)

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016)

Concurrent Hepatitis C and B Virus and Human Immunodeficiency Virus Infections Are Associated With Higher Mortality Risk Illustrating the Impact of Syndemics on Health Outcomes
por: Butt, Zahid A, et al.
Publicado: (2020)

Assessment of the Feasibility and Cost of Hepatitis C Elimination in Pakistan
por: Chhatwal, Jagpreet, et al.
Publicado: (2019)

Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in Canada
por: Darvishian, Maryam, et al.
Publicado: (2021)

Twin epidemics of new and prevalent hepatitis C infections in Canada: BC Hepatitis Testers Cohort
por: Janjua, Naveed Zafar, et al.
Publicado: (2016)

The challenges of viral hepatitis elimination: a global response to a global problem
por: Black, Antony P., et al.
Publicado: (2023)

Correction: The challenges of viral hepatitis elimination: a global response to a global problem
por: Black, Antony P., et al.
Publicado: (2023)

HCV elimination among people who inject drugs. Modelling pre- and post–WHO elimination era
por: Gountas, Ilias, et al.
Publicado: (2018)

Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress
por: Blach, Sarah, et al.
Publicado: (2023)

Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019
por: Pearce, Margo E., et al.
Publicado: (2020)

Impact of Hepatitis B Virus Infection, Non-alcoholic Fatty Liver Disease, and Hepatitis C Virus Co-infection on Liver-Related Death among People Tested for Hepatitis B Virus in British Columbia: Results from a Large Longitudinal Population-Based Cohort Study
por: Makuza, Jean Damascene, et al.
Publicado: (2022)

Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health
por: O’Brien, Sheila F., et al.
Publicado: (2023)

Impact of COVID-19 on global HCV elimination efforts
por: Blach, Sarah, et al.
Publicado: (2021)

Association between close interpersonal contact and vaccine hesitancy: Findings from a population-based survey in Canada
por: Adu, Prince A., et al.
Publicado: (2022)

Impact of Seasonal and Pandemic Influenza on Emergency Department Visits, 2003–2010, Ontario, Canada
por: Schanzer, Dena L, et al.
Publicado: (2013)

The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada
por: Chu, Cherry, et al.
Publicado: (2023)

Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia
por: Jeong, Dahn, et al.
Publicado: (2021)

Chronic hepatitis C infection is associated with higher incidence of extrahepatic cancers in a Canadian population based cohort
por: Darvishian, Maryam, et al.
Publicado: (2022)

Estimating Influenza Deaths in Canada, 1992–2009
por: Schanzer, Dena L, et al.
Publicado: (2013)

Disease burden of hepatitis C in the Austrian state of Tyrol – Epidemiological data and model analysis to achieve elimination by 2030
por: Schaefer, Benedikt, et al.
Publicado: (2018)

Statistical estimates of respiratory admissions attributable to seasonal and pandemic influenza for Canada
por: Schanzer, Dena L., et al.
Publicado: (2013)

Cost-effectiveness modelling of birth and infant dose vaccination against hepatitis B virus in Ontario from 2020 to 2050
por: Biondi, Mia J., et al.
Publicado: (2023)

Use of latent class analysis and patient reported outcome measures to identify distinct long COVID phenotypes: A longitudinal cohort study
por: Wong, Alyson W., et al.
Publicado: (2023)

Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion
por: Wilton, James, et al.
Publicado: (2022)

The Impact of Mask Mandates on Face Mask Use During the COVID-19 Pandemic: Longitudinal Survey Study
por: Binka, Mawuena, et al.
Publicado: (2023)

The Geographic Synchrony of Seasonal Influenza: A Waves across Canada and the United States
por: Schanzer, Dena L., et al.
Publicado: (2011)

Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study
por: Pearce, Margo E., et al.
Publicado: (2021)

Contact patterns during the COVID-19 pandemic: findings from British Columbia, Canada
por: Adu, P., et al.
Publicado: (2022)

Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
por: Estes, Chris, et al.
Publicado: (2017)

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
por: Naveed, Zaeema, et al.
Publicado: (2022)

Economic evaluation of the hepatitis C elimination strategy in Greece in the era of affordable direct-acting antivirals
por: Gountas, Ilias, et al.
Publicado: (2019)

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan
por: Sagan, Selena M., et al.
Publicado: (2016)

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
por: Blach, Sarah, et al.
Publicado: (2021)

Ten years countdown to hepatitis C elimination in Belgium: a mathematical modeling approach
por: Busschots, Dana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hisucka3a7jsejkdhqj12618sk